Silverarc Capital Management »

Mersana Therapeutics Inc call shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Mersana Therapeutics Inc call shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Mersana Therapeutics Inc call

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics Inc call held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics Inc call by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $338k 168k 2.01
2024-03-31 $7.6k 1.7k 4.48

More positions owned by Silverarc Capital Management

Nuvalent Inc-a (NUVL)
Merus N V (MRUS)
Insmed Com Par $.01 (INSM)
Avidity Biosciences Ord (RNA)
Erasca (ERAS)
Akero Therapeutics (AKRO)
Veracyte (VCYT)
Rhythm Pharmaceuticals (RYTM)
Cogent Biosciences (COGT)
Intra Cellular Therapies (ITCI)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Urogen Pharma (URGN)
Oric Pharmaceuticals (ORIC)
Poseida Therapeutics I (PSTX)
Verona Pharma Sponsored Ads (VRNA)

View all positions for Silverarc Capital Management

Top funds holding Mersana Therapeutics Inc call

Simplex Trading
Group One Trading

View all funds holding Mersana Therapeutics Inc call